BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation theory of tons in a single day. The Federal Trade Commission doesn't think that's significant." Hunt used this real-life message as an inoculation treatment in his research (Lessne and Didow, 1987). He used the corrective campaign by the FTC as the attack on the positive attitude toward Chevron. The results indicated that a supportive treatment offered less resistance than a refutational treatment. The other discovery was that when an inoculative treatment is received, but no attack is followed there is a drop in attitude. One of the major limitations in this study was that Hunt did not allow a time elapse